Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|January 1, 2005
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigensLi Li, Peter Reinhardt, Anita Schmitt, et al.
Cancer Medicine|December 14, 2020
Characteristics and mechanisms to control a COVID-19 outbreak on a leukemia and stem cell transplantation unitJochen Greiner, Marlies Götz, Waltraud Malner-Wagner, et al.
Science (New York, N.Y.)|August 2, 2014
Early ⁵⁶Ni decay gamma rays from SN2014J suggest an unusual explosionRoland Diehl, Thomas Siegert, Wolfgang Hillebrandt, et al.
Elife|April 30, 2021
De novo macrocyclic peptides dissect energy coupling of a heterodimeric ABC transporter by multimode allosteric inhibitionErich Stefan, Richard Obexer, Susanne Hofmann, et al.
Experimental Hematology|September 13, 2002
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemiaJochen Greiner, Mark Ringhoffer, Masanori Taniguchi, et al.
Experimental Hematology|December 13, 2006
Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory moleculesMichael Schmitt, Li Li, Krzysztof Giannopoulos, et al.
Regenerative Medicine|May 1, 2007
Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo applicationJuliane M I Wiehe, Carola Niesler, Jan Torzewski, et al.
Cancer Immunity|July 17, 2003
Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemiaLi Li, Anita Schmitt, Peter Reinhardt, et al.
Blood|April 14, 2005
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemiaJochen Greiner, Li Li, Mark Ringhoffer, et al.
International Journal of Oncology|March 10, 2006
Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blastsLi Li, Krzysztof Giannopoulos, Peter Reinhardt, et al.
Pageof 9